TNXP R&D to Revenue
Tonix Pharmaceuticals Holding Corp · R&D to Revenue
TNXP R&D to Revenue
Latest reported339.41%period ending
TNXP FY R&D/Revenue (0.00% → 339.41%)
Latest values, visible window
High-resolution chart · PNG
TNXP r&d to revenue history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D to Revenue |
|---|---|
| 339.4064% | |
| 400.7133% | |
| 1,115.5381% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% |